Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Increases By 57.1%

GlucoTrack, Inc. (NASDAQ:GCTK) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 24,200 shares, an increase of 57.1% from the September 15th total of 15,400 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 16,100 shares, the short-interest ratio is currently 1.5 days.

GlucoTrack Stock Down 3.0 %

Shares of GCTK stock traded down $0.07 during trading hours on Monday, hitting $2.16. 4,132 shares of the company’s stock traded hands, compared to its average volume of 26,314. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 0.52. The stock’s fifty day simple moving average is $2.30 and its two-hundred day simple moving average is $2.25. GlucoTrack has a 12-month low of $0.66 and a 12-month high of $4.95. The stock has a market cap of $11.83 million, a price-to-earnings ratio of -1.09 and a beta of 0.13.

GlucoTrack (NASDAQ:GCTK) last issued its quarterly earnings results on Tuesday, August 13th. The company reported ($0.82) earnings per share for the quarter.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.